doi: 10.1200/JOP.2015.005215.
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Affiliations
- PMID: 29424583
- DOI: 10.1200/JOP.2015.005215
Item in Clipboard
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
J Oncol Pract.
2015 Nov.
No abstract available
Similar articles
-
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.J Oncol Pract. 2016 Apr;12(4):384-9. doi: 10.1200/JOP.2016.010868. Epub 2016 Mar 8. J Oncol Pract. 2016. PMID: 26957642 No abstract available.
-
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol. 2015 Aug 20;33(24):2695-704. doi: 10.1200/JCO.2015.61.1459. Epub 2015 Jul 20. J Clin Oncol. 2015. PMID: 26195705 Free PMC article.
-
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.J Clin Oncol. 2000 Mar;18(6):1378-91. doi: 10.1200/JCO.2000.18.6.1378. J Clin Oncol. 2000. PMID: 10715310
-
American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.J Clin Oncol. 2011 Oct 10;29(29):3939-42. doi: 10.1200/JCO.2011.36.4950. Epub 2011 Sep 6. J Clin Oncol. 2011. PMID: 21900112 Review.
-
American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.J Clin Oncol. 2007 Nov 20;25(33):5313-8. doi: 10.1200/JCO.2007.13.4536. Epub 2007 Oct 9. J Clin Oncol. 2007. PMID: 17925542 Review.
Cited by
-
Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer.Cancer Cell Int. 2024 Mar 19;24(1):109. doi: 10.1186/s12935-024-03298-1. Cancer Cell Int. 2024. PMID: 38504252 Free PMC article.
-
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer.Breast Cancer Res Treat. 2024 Apr;204(3):617-629. doi: 10.1007/s10549-023-07210-9. Epub 2024 Jan 6. Breast Cancer Res Treat. 2024. PMID: 38183515 Free PMC article.
-
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.Breast Cancer. 2024 Mar;31(2):217-227. doi: 10.1007/s12282-023-01524-8. Epub 2023 Dec 9. Breast Cancer. 2024. PMID: 38070067
-
Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor.J Pathol Transl Med. 2023 Jul;57(4):217-231. doi: 10.4132/jptm.2023.06.10. Epub 2023 Jul 11. J Pathol Transl Med. 2023. PMID: 37460396 Free PMC article.
-
Significance of circulating tumor cells in lung cancer: a narrative review.Transl Lung Cancer Res. 2023 Apr 28;12(4):877-894. doi: 10.21037/tlcr-22-712. Epub 2023 Mar 29. Transl Lung Cancer Res. 2023. PMID: 37197632 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
